By Counterforce Health Team in Rystiggo (rozanolixizumab-noli) —

How to Get Rystiggo (Rozanolixizumab-noli) Covered by Cigna in Michigan: Prior Authorization, Appeals, and Forms Guide

Answer Box: Getting Rystiggo Covered by Cigna in Michigan

Rystiggo (rozanolixizumab-noli) requires prior authorization from Cigna for myasthenia gravis treatment. You'll need antibody testing (AChR or MuSK positive), documented standard therapy trials, and MG-ADL scores ≥3. Your neurologist submits the PA through CoverMyMeds or ExpressPAth. If denied, file internal appeals within 180 days, then external review with Michigan DIFS within 127 days. Start today: Contact your neurologist to initiate the prior authorization process and gather required documentation.

Table of Contents

  1. Plan Types & Coverage Implications
  2. Formulary Status & Tier Placement
  3. Prior Authorization Requirements
  4. Specialty Pharmacy Requirements
  5. Cost-Share Dynamics
  6. Submission Process
  7. Appeals Process in Michigan
  8. Common Denial Reasons & Solutions
  9. FAQ

Plan Types & Coverage Implications

Cigna Plan Differences in Michigan

HMO Plans: Require a primary care physician (PCP) and referrals to see specialists like neurologists. Your PCP must coordinate care and provide referrals for Rystiggo treatment. Out-of-network care isn't covered except in emergencies.

PPO Plans: Offer more flexibility with larger networks. You can see any neurologist in-network without referrals, though out-of-network care costs more. This flexibility can be valuable for accessing myasthenia gravis specialists.

EPO Plans: Provide network access without referrals but don't cover out-of-network care except emergencies. No PCP selection required, making specialist access easier than HMO plans.

Note: All plan types require the same prior authorization for Rystiggo, but HMO members must ensure their neurologist is in-network and obtain proper referrals.

Formulary Status & Tier Placement

Rystiggo typically appears on Tier 4 or 5 (specialty tier) of Cigna formularies, requiring prior authorization regardless of plan type. As a high-cost biologic for a rare condition, it's subject to strict utilization management.

Alternative Agents: Cigna may prefer step therapy with:

  • Vyvgart (efgartigimod) - another FcRn inhibitor
  • Soliris (eculizumab) - complement inhibitor
  • Standard therapies: pyridostigmine, corticosteroids, IVIG

Check your specific formulary at Cigna's prescription drug lists page to confirm Rystiggo's status and any preferred alternatives.

Prior Authorization Requirements

Clinical Documentation Required

Antibody Testing: Must demonstrate either:

  • Anti-AChR antibody-positive generalized myasthenia gravis, OR
  • Anti-MuSK antibody-positive generalized myasthenia gravis

Disease Severity: MG-ADL score ≥3 for non-ocular symptoms, with MGFA classification II-IV documented in clinical notes.

Standard Therapy Trials: Documentation of:

  • Current or prior pyridostigmine use (or contraindication/intolerance)
  • Evidence of inadequate response to standard immunosuppressive therapies
  • Ongoing symptoms affecting swallowing, breathing, mobility, or speech

Prescriber Requirements: Must be prescribed by or in consultation with a neurologist.

Coverage at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required for all plans Cigna provider portal Cigna PA Requirements
Antibody Testing AChR or MuSK positive Lab results in chart Cigna Rystiggo Policy
MG-ADL Score ≥3 for approval Clinical assessment Cigna Rystiggo Policy
Neurologist Rx Specialist required Provider credentials Cigna Rystiggo Policy
Initial Approval 6 months PA determination Cigna Rystiggo Policy

Specialty Pharmacy Requirements

Rystiggo requires Accredo specialty pharmacy handling for Cigna members. Once prior authorization is approved:

  1. Prescription Routing: Your neurologist sends the prescription to Accredo (not your local pharmacy)
  2. Patient Setup: Accredo contacts you to establish services and coordinate delivery
  3. Administration: Medication ships to your home or provider's office for subcutaneous injection
  4. Refill Coordination: Contact Accredo at 877-826-7657 approximately two weeks before your next cycle
Tip: Accredo provides clinical support, adherence counseling, and manufacturer copay assistance coordination as part of their service.

Cost-Share Dynamics

Specialty Tier Costs: Expect higher out-of-pocket costs on Tier 4/5, typically:

  • Coinsurance: 25-40% of drug cost
  • Monthly maximums may apply
  • Deductible requirements common

Manufacturer Support: UCB offers patient assistance programs. Contact them directly or ask Accredo to help connect you with available programs.

Foundation Grants: Organizations like the Patient Access Network Foundation may provide copay assistance for myasthenia gravis treatments.

Submission Process

Step-by-Step: Fastest Path to Approval

  1. Gather Documentation (Patient + Clinic)
    • Insurance card and member ID
    • Complete medical records showing antibody results
    • MG-ADL scores and MGFA classification
    • Prior therapy documentation
  2. Neurologist Submits PA (Clinic)
    • Use CoverMyMeds or ExpressPAth portal
    • Include all required clinical documentation
    • Timeline: Real-time processing possible
  3. Cigna Reviews (Insurer)
    • Standard review: 72 hours for formulary exceptions
    • Medical necessity review: up to 30 days
    • Expedited available if medically urgent
  4. Approval Notification (All parties)
    • Provider and pharmacy notified
    • Patient receives approval letter
    • Accredo begins coordination
  5. If Denied, Appeal Immediately (Patient + Clinic)
    • File within 180 days of denial
    • Include additional clinical evidence
    • Request peer-to-peer review

Appeals Process in Michigan

Internal Appeals with Cigna

Timeline: File within 180 calendar days of denial date

Standard Review: Cigna responds within 30 days

Expedited Review: Available if delay could jeopardize health - decision within 72 hours

Required Documentation:

  • Cigna Appeal Form
  • Additional clinical evidence
  • Neurologist's medical necessity letter
  • Peer-reviewed literature supporting off-label use (if applicable)

External Review with Michigan DIFS

If Cigna denies your internal appeal, you can request external review through Michigan's Department of Insurance and Financial Services.

Timeline: File within 127 days of Cigna's final denial

Standard Decision: Within 45 days

Expedited Decision: Within 72 hours (requires physician certification of urgency)

How to File:

  • Complete Michigan's "Health Care Request for External Review" form
  • Submit online, by mail, fax, or email to DIFS
  • Include all denial letters and supporting documentation
  • Contact DIFS at 877-999-6442 for assistance
Important: External review decisions are binding - if DIFS overturns the denial, Cigna must provide coverage.

Common Denial Reasons & Solutions

Denial Reason How to Overturn
Missing antibody documentation Submit lab results showing AChR or MuSK positive status
Insufficient MG-ADL score Provide detailed clinical assessment with score ≥3
Lack of standard therapy trials Document pyridostigmine use and immunosuppressive therapy attempts
Not prescribed by neurologist Ensure neurologist submits or co-signs the request
Quantity limits exceeded Provide weight-based dosing calculations and clinical rationale

Clinician Corner: Medical Necessity Letter Checklist

Essential Elements:

  • Patient's specific diagnosis with ICD-10 codes
  • Antibody test results (AChR or MuSK positive)
  • Current MG-ADL score and MGFA classification
  • Detailed prior therapy history and outcomes
  • Clinical rationale for Rystiggo specifically
  • Weight-based dosing calculations
  • Treatment goals and monitoring plan

Supporting Evidence:

  • FDA prescribing information
  • American Academy of Neurology guidelines
  • Peer-reviewed studies on FcRn inhibition
  • Patient-specific contraindications to alternatives

Counterforce Health helps clinicians create evidence-backed appeals by analyzing denial letters, plan policies, and clinical notes to draft targeted rebuttals aligned with payer requirements. The platform identifies specific denial reasons and pulls appropriate citations from FDA labeling, peer-reviewed studies, and specialty guidelines.

FAQ

How long does Cigna prior authorization take for Rystiggo in Michigan? Standard PA review takes up to 72 hours for formulary exceptions and up to 30 days for medical necessity determinations. Real-time processing is possible through electronic portals like CoverMyMeds.

What if Rystiggo is non-formulary on my Cigna plan? You can request a formulary exception with clinical justification. Your neurologist must demonstrate medical necessity and provide evidence that formulary alternatives are inappropriate.

Can I request an expedited appeal if denied? Yes, if waiting for standard review could seriously jeopardize your health. Your physician must certify the urgency, and Cigna must respond within 72 hours for internal appeals.

Does step therapy apply to Rystiggo? Cigna typically requires documentation of standard MG therapies (pyridostigmine, immunosuppressants) before approving Rystiggo, though formal step therapy protocols may vary by plan.

What happens if I move from Michigan to another state? Appeal rights and timelines may differ by state. Contact your new state's insurance department for external review procedures if needed.

How much will Rystiggo cost with Cigna coverage? Costs depend on your specific plan's specialty tier structure, deductible, and coinsurance. Expect significant out-of-pocket costs, but manufacturer assistance programs may help reduce your share.

For additional support navigating the prior authorization and appeals process, Counterforce Health provides specialized assistance for patients, clinicians, and pharmacies dealing with insurance denials for prescription drugs.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies and procedures may change. Always verify current requirements with Cigna and consult your healthcare provider for medical decisions. For assistance with Michigan insurance appeals, contact DIFS at 877-999-6442.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.